Nexium Maker Wants Antitrust Claims Handled By Patent Judge
AstraZeneca PLC argued Thursday before the U.S. Judicial Panel on Multidistrict Litigation that putative antitrust class actions alleging it wrongly kept generic versions of its Nexium drug off the market should...To view the full article, register now.
Already a subscriber? Click here to view full article